NeuroMedix preparing for phase I Alzheimer's Drug Trial

CNW Group: "NeuroMedix Inc. ('NeuroMedix') (TSXV: NMX) today announced that it has produced its first kilogram-scale batch of clinical grade cGMP (current Good Manufacturing Practice) Minozac for late stage pre-clinical toxicology studies and for human safety Phase I studies."

The company expects to submit a regulatory filing for the initiation of a trial by the end of 2006.